
GSK plc
GSKHealthcare · Stock · quarterly payer
Forward Yield
3.62%
Annual Dividend
$1.82
Payout Ratio
57%
5-Yr Growth
-4.0%
Ex-Date
Aug 14, 2026
Frequency
Quarterly
Summary
As of September 2026, GSK plc (GSK) yields 3.62% ($1.82 per share annually), with a blended fair-value estimate of $54.84 — +9% upside, so it screens as fairly valued. Dividend safety grade: C (55/100). 2 years of dividend growth.
Is GSK a good dividend stock?
MixedGSK plc (GSK) pays a quarterly dividend yielding 3.62% ($1.82/yr), with 2 years of growth and a dividend-safety grade of C. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal.
Advantages
- Comfortable payout ratio (57%)
Risks
- Cut its dividend in 2023
- Dividend has been shrinking, not growing
Key Data
- Dividend Yield
- 3.62%
- Payout Ratio
- 57%
- Annual Dividend
- $1.82
- 5-Yr Avg Growth
- -4.0%
- Ex-Dividend Date
- Aug 14, 2026
- Years of Growth
- 2
- Frequency
- quarterly
- Beta
- 0.29
- Market Cap
- $100.6B
- P/E Ratio
- 15.9
- 5-Yr Total Return
- 19%
- 52-Week Range
- $39.29 – $61.70
- Dividend Safety
- C · 55/100
- Ever Cut?
- Yes (2023)
Frequently Asked Questions
GSK Price — Last 12 Months
Daily close
Price Return
1 Year
+7%
3 Years
+41%
5 Years
+19%
52-Week Range
$39.29 – $61.70
Price change over each period (excludes dividends). Past performance doesn't guarantee future results.
What is GSK worth?
Fairly valuedhigh confidenceOur blended fair-value estimate for GSK plc is $54.84 per share, versus a market price of $50.22. That implies the stock is roughly fairly priced.
Fair Value
$54.84
Current Price
$50.22
Gap
+9%
Margin of Safety
8%
How we get there
Discounted cash flow
Discounts projected free cash flow back to today.
Dividend discount
Discounts the future dividend stream back to today.
Earnings multiple (Graham)
Graham's earnings-multiple formula, anchored to bond yields.
At today's price, the market is pricing in about 1.9% annual free-cash-flow growth. We model 5.3% — below our estimate, leaving room for upside if the business executes.
Assumptions: 7.0% discount rate (CAPM), 5.3% stage-1 growth, 2.5% terminal growth, $3.15 EPS, $1.82 annual dividend. Updated weekly.
Fair-value estimates are model output for educational purposes only — not investment advice or a price target.
GSK Dividend Safety Score
Borderline
SmarterDividends' proprietary score, backtested against which dividends were actually cut over 15+ years (0.78 AUC). It blends a validated cut-risk model (growth streak, cut history) with current payout, cash-flow and debt. Higher is safer · not investment advice.
Dividend Growth
Total dividends per share by year
Dividend History
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| Aug 14, 2026 | — | $0.4520 | regular |
| May 15, 2026 | — | $0.4610 | regular |
| Feb 20, 2026 | — | $0.4860 | regular |
| Nov 14, 2025 | — | $0.4170 | regular |
| Aug 15, 2025 | — | $0.4280 | regular |
| May 16, 2025 | — | $0.4290 | regular |
| Feb 21, 2025 | — | $0.4010 | regular |
| Nov 15, 2024 | — | $0.3890 | regular |
| Aug 16, 2024 | — | $0.3860 | regular |
| May 16, 2024 | — | $0.3760 | regular |
| Feb 22, 2024 | — | $0.4060 | regular |
| Nov 16, 2023 | — | $0.3400 | regular |
| Aug 17, 2023 | — | $0.3610 | regular |
| May 18, 2023 | — | $0.3480 | regular |
Income Calculator
At $1.82 / yr per share
Similar Dividend Stocks
Compare GSK
Explore more
Lists and tools related to GSK




